60
35
Growth Score
-20 pts
Heat Score
-17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
378413
AUROBAC THERAPEUTICS develops precision medicines to fight antimicrobial resistance.
About the Company
Aurobac Therapeutics is a biopharmaceutical company that focuses on the development of precision medicines. The company's primary goal is to combat antimicrobial resistance (AMR), a significant global health concern. Aurobac Therapeutics was established as a joint venture by three life sciences innovation companies. The company's
leadership includes CEO Florence Séjourné and Chairman Manos Perros. Aurobac Therapeutics is committed to innovation and research in the field of biopharmaceuticals, with a particular emphasis on addressing AMR.
